Abstract:Background: The aim of this study was to investigate and discuss the salbutamol combined with budesonide in treatment of pediatric bronchial asthma (BA) and its effect on eosinophils (EOS). Methods: Ninety-eight BA children admitted and treated in our hospital from July 2016 to June 2017 were collected and divided into control group (N.=49) and observation group (N.=49) according to random number table. The children in control group were treated with budesonide and those in observation group were treated with salbutamol combined with budesonide. The clinical efficacy, pulmonary functions and levels of T-lymphocyte subsets (including cluster of differentiation 3 (CD3)+, CD4+, CD8+ and CD4+/CD8+) in the immune system between two groups were compared after the treatment; the levels of eosinophil cationic protein (ECP) and eotaxin in the children were compared before the treatment and at 1, 4 and 8 weeks after the treatment; the changes in EOS counts in blood and induced sputum of the children before and after the treatment were compared, and the EOS apoptosis rate was compared at 1, 4 and 8 weeks after the treatment. Results: The effective rate of treatment in observation group was significantly higher than that in control group (P<0.05). After the treatment, the indexes of pulmonary function in observation group were obviously better than those in control group (P<0.05). Compared with those in control group, the levels of CD3+, CD4+ and CD4+/CD8+ of the children in observation group were elevated remarkably, while the CD8+ level was lowered (P<0.05). The levels of ECP and eotaxin in the two groups were decreased after the treatment compared with those before the treatment, and the levels in observation group were superior to those in control group (P<0.05). After the treatment, the EOS counts of both groups of children were lower than those before the treatment, and the decrease in observation group was more notable than that in control group. At 1, 4 and 8 weeks after the treatment, the EOS apoptosis rate in observation group was obviously higher than that in control group (P<0.05). Conclusions: The treatment of salbutamol combined with budesonide for pediatric BA has significant therapeutic effects; it can restore the pulmonary functions rapidly and improve the immunity of the lung, reduce the levels of eotaxin, ECP and EOS of the child patients and promote EOS apoptosis.

Budesonide Suspension for Inhalation Ease Analysis of Patients With Acute Attack of Bronchial Asthma in Adult

Budesonide in Combination with Salbutamol in the Treatment of 61 Cases of Childhood Bronchial Asthma During Acute Episodes

A Three-Month Non-Interventional Study of Asthma Treatment with Budesonide/Formoterol

Evaluating the Efficacy of Budesonide Suspension for Inhalation on Treating Acute Exacerbation Phase of COPD

The Efficacy of Budesonide-formoterol in Patients with Acute Attacks of Mild-to-moderate Bronchial Asthma: An Observational Study

Inhaled budesonide versus oral prednisolone in the treatment of acute exacerbation of moderate bronchial asthma: an open label randomized clinical trial

Clinical Efficacy of Budesonide and Formoterol Fumarate Powder in the Treatment of Patients with Bronchial Asthma and Its Effect on the Serum Levels of Inflammatory Factors

Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma

Nebulized budesonide in treatment of acute exacerbation of chronic obstructive pulmonary disease

Effects of Budesonide Plus Vitamin AD on Children with Bronchial Asthma and the Effect on Serum IgE and C-reactive Protein

Budesonide/Fomoterol in combination with Montelukast in the treatment of Bronchial Asthma.

Influence Analysis of Salmeterol Fluticasone and Budesonide to Lung Function of Patients with Bronchial Asthma

Inhalation of Β_2-Agonist,anticholinergics and Glucocorticosteroid in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease

Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma

Clinical study on inhalation of budesonid with nebulizer in the treatment of children with asthma

Meta-analysis on the efficacy of nebulized budesonide and salbutamol in the treatment of asthma

Effects of budesonide combined with salbutamol on pulmonary function and peripheral blood eosinophiles and IgE in patients with acute attack of bronchial asthma

Salbutamol combined with budesonide in treatment of pediatric bronchial asthma and its effect on eosinophils

Efficacy of Budesonide Suspension Fluid Inhalation in Treatment of Wheezing in Infants

Efficacy and Safety of Montelukast Sodium Tablets Combined with Budesonide Suspension in the Treatment of Patients with Bronchial Asthma

Terbutaline, Budesonide, Inhalation of Ambroxol Combined with Clinical Observation on the Treatment of Children with Bronchiolitis